Wegmann v. Ethicon, Inc.

District Court, E.D. Missouri·Decided October 8, 2020·No. 4:20-cv-00704·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION

ANNE WEGMANN, ) ) Plaintiff, ) ) v. ) No. 4:20-CV-00704 JAR ) ETHICON, INC., et al., ) ) Defendants. )

MEMORANDUM AND ORDER

This matter is before the Court on Plaintiff’s Motion to Exclude Opinions and Testimony of Charles Butrick, M.D. (Doc. No. 43); and Plaintiff’s Motion To Strike Defendants’ Experts That Exceed The Five (5) Expert Limit Set Forth By Pre-Trial Order #328 and To Limit Defendants’ Employees From Offering Expert Opinions (Doc. No. 69). The motions are fully briefed and ready for disposition.1 I. Background This matter was recently transferred to this Court from multi-district litigation (“MDL”) in the United States District Court for the Southern District of West Virginia. In re Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation, No. 2:12-md-2327 (S.D. W.Va.). The MDL involves claims of harm resulting from implantation of various polypropylene-based mesh products, including tension-free vaginal tape (“TVT”). On May 14, 2003, Plaintiff underwent implantation of Ethicon’s TVT Retropubic Support System for treatment of stress urinary incontinence (“SUI”). The surgery was performed by Dr. Robert Feit in St. Louis, Missouri.

1 On October 8, 2020, Plaintiffs filed a notice of supplemental authority in support of their motion to strike (Doc. No. 90), which the Court has considered. Within one year of implantation, Plaintiff began to experience a number of physical problems; in 2015, she underwent surgery to remove the TVT. On November 10, 2014, Plaintiff filed a “Short Form Complaint,” incorporating the First Amended Master Long Form Complaint, against Ethicon and Johnson & Johnson (collectively “Ethicon”) in the MDL. Plaintiff alleges numerous

causes of action against Ethicon, including negligence, strict liability, and fraud. (Doc. No. 1). II. Motion to exclude opinions and testimony of Charles Butrick, M.D. Ethicon has designated Charles Butrick, M.D., a urogynecologist and specialist in pelvic floor disorders, to provide case-specific expert opinions related to causation in this case. Plaintiff moves to exclude Dr. Butrick’s opinions and testimony as based on insufficient facts and unreliable methodology. A. Legal standard The admission of expert testimony in federal court is governed by Federal Rule of Evidence 702. A district court acts as a “gatekeeper” when screening expert testimony for relevance and reliability. Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579, 590-93 (1993);

Russell v. Whirlpool Corp., 702 F.3d 450, 456 (8th Cir. 2012). To satisfy the reliability requirement, the party offering the expert testimony “must show by a preponderance of the evidence both that the expert is qualified to render the opinion and that the methodology underlying his conclusions is scientifically valid.” Barrett v. Rhodia, Inc., 606 F.3d 975, 980 (8th Cir. 2010) (quoting Marmo v. Tyson Fresh Meats, Inc., 457 F.3d 748, 757 (8th Cir. 2006)). To satisfy the relevance requirement, the proponent must show that the expert’s reasoning or methodology was applied properly to the facts at issue. Id. The Court in Daubert emphasized that the inquiry required by FRE 702 is intended to be flexible. 509 U.S. at 594. The Daubert analysis was extended to all expert testimony, as opposed to only “scientific” testimony. Kumho Tire Co., Ltd. v. Carmichael, 526 U.S. 135, 147 (1999). Due to the liberalization of expert testimony admission standards signaled by Daubert and its progeny, and the codification of this trend by FRE 702, the Eighth Circuit has held that expert testimony should be liberally admitted. Johnson v. Mead Johnson & Co., LLC, 754 F.3d 557,

562 (8th Cir. 2014) (citing United States v. Finch, 630 F.3d 1057, 1062 (8th Cir. 2011) (doubts about usefulness of expert testimony are resolved in favor of admissibility)); Robinson v. GEICO Gen. Ins. Co., 447 F.3d 1096, 1100 (8th Cir. 2006) (expert testimony should be admitted if it advances the trier of fact’s understanding “to any degree”); Lauzon v. Senco Prod., Inc., 270 F.3d 681, 686 (8th Cir. 2001) (FRE 702 “clearly is one of admissibility rather than exclusion”) (quotations omitted). As long as the expert testimony rests upon “good grounds, based on what is known,” it should be tested by the adversary process with competing expert testimony and cross- examination, rather than excluded at the outset. Id. (citing Daubert, 509 U.S. at 596). Exclusion of an expert opinion is proper “only if it is so fundamentally unsupported that it can offer no assistance to the jury.” Wood v. Minnesota Mining & Mfg. Co., 112 F.3d 306, 309 (8th Cir.

1997) (citation and quotation marks omitted). B. Discussion Plaintiff seeks to exclude several of Dr. Butrick’s opinions: (1) “general opinions in [Plaintiff’s] case that are not specific to this Plaintiff” (Doc. No. 44 at 5-7); (2) opinions “based solely upon his ‘clinical experience’ and ‘position statements’” (id. at 7-8); (3) opinions regarding the appropriateness of treatment rendered by Plaintiff’s treating physicians, Dr. Feit and Dr. Veronikis, and whether they deviated from the applicable standard of care (id. at 8-13); (4) opinions identifying certain alternative causes for Plaintiff’s alleged injuries, such as hypertonic pelvic floor dysfunction, pelvic floor myalgia, low back/hip pain, and degenerative disc disease (id. at 13-17); and (5) opinions offered during Dr. Butrick’s deposition that were purportedly not contained in his expert report (id. at 17-19). The Court will address each challenged opinion in turn. (1) General opinions

First, Plaintiff seeks to exclude Dr. Butrick’s general opinions that are not specific to Plaintiff, including, inter alia, his opinions that the TVT is the “gold standard” for treatment of SUI; that the benefits of the TVT outweigh the risks; that the TVT does not have any design defects and is safe and effective; that the Instructions for Use (“IFU”) for the TVT is “not misleading and adequately warned surgeons of potential complications;” and that there are and were no safer alternative designs compared to the TVT for treatment of SUI. (Case Specific Report of Dr. Charges Butrick, M.D. (“Butrick Report”), Doc. No. 43-1 at 3-4, 18). In response, Ethicon states that Dr. Butrick has not been designated as a general expert in this case and will not offer any general opinions related to the TVT device at trial. (Doc. No. 46 at 2). For this reason, Plaintiff’s motion to exclude Dr. Butrick’s general opinions will be denied

Free access — add to your briefcase to read the full text and ask questions with AI

Wegmann v. Ethicon, Inc., (E.D. Mo. 2020).

Wegmann v. Ethicon, Inc. (Wegmann v. Ethicon, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Barrett v. Rhodia, Inc.
606 F.3d 975 (Eighth Circuit, 2010)
United States v. Finch
630 F.3d 1057 (Eighth Circuit, 2011)
Fred Lauzon v. Senco Products, Inc.
270 F.3d 681 (Eighth Circuit, 2001)
Karla Robinson v. Geico General Insurance Company
447 F.3d 1096 (Eighth Circuit, 2006)
Randy Russell v. Whirlpool Corp.
702 F.3d 450 (Eighth Circuit, 2012)
Rivera v. Florida Department of Corrections
526 U.S. 135 (Supreme Court, 1999)
Scott Johnson v. Mead Johnson & Company
754 F.3d 557 (Eighth Circuit, 2014)
Carol Marmo v. Tyson Fresh Meats
457 F.3d 748 (Eighth Circuit, 2006)
Westberry v. Gislaved Gummi AB
178 F.3d 257 (Fourth Circuit, 1999)
Eghnayem v. Boston Scientific Corp.
57 F. Supp. 3d 658 (S.D. West Virginia, 2014)